ResearcherKaohsiung Medical UniversityNo recent work listed
Sheng‐Kai Hsu
Matched on ORCID iD 0000-0003-2583-9569; OpenAlex author ID A5084070313. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2022: 2 papers · 2023: 1 paper
Papers 3
- The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers. Co-author DOI 10.3390/cancers15061776↗
- Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components. Co-author DOI 10.3389/fmolb.2022.1020888↗
- The Role of Nonapoptotic Programmed Cell Death - Ferroptosis, Necroptosis, and Pyroptosis - in Pancreatic Ductal Adenocarcinoma Treatment. Co-author DOI 10.3389/fonc.2022.872883↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chien‐Chih Chiu · 3 shared papers, 2022–2023 · strength 0.56
- Paper The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers. DOI 10.3390/cancers15061776↗
- Paper Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components. DOI 10.3389/fmolb.2022.1020888↗
- Paper The Role of Nonapoptotic Programmed Cell Death - Ferroptosis, Necroptosis, and Pyroptosis - in Pancreatic Ductal Adenoc… DOI 10.3389/fonc.2022.872883↗
- Chia‐Hung Yen · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.